The present study examined the bactericidal effects of orexin B (ORXB) and vasoactive intestinal peptide (VIP) alone or combined with cationic antimicrobial peptides, such as LL-37, on Escherichia coli, Pseudomonas aeruginosa, Streptococcus mutans and Staphylococcus aureus. The bactericidal effect of ORXB or VIP alone was detected in low NaCl concentration, but attenuated in physiological NaCl concentration (150 mM). However, such attenuated bactericidal activities of ORXB and VIP in 150 mM NaCl were regained by adding LL-37. Therefore, our results indicate that VIP and ORXB appear to mediate bactericidal effects in concert with LL-37 in the physiological context of mucosal tissue.
Introduction
In general, neurons produce both a conventional chemical neurotransmitter and one or more neuropeptides. Neuropeptides function as neurotransmitters in the brain and the peripheral nervous system. However, they also play roles in regulating immune function and neurogenic inflammatory responses through vasodilatation, plasma extravasation, and recruitment of immunocompetent cells (Toriya et al., 1997; Jonsdottir, 2000) . Furthermore, recent studies revealed that some neuropeptides released from the neuroendocrine system, such as Neurokinin-1 (NK-1) and neuropeptide Y (NPY), have antimicrobial properties (Brogden et al., 2005) . Vasoactive intestinal polypeptide (VIP) is widely expressed in the central nervous system, as well as peripheral tissues, including the lung, stomach, skin, and oral cavity, where it has been shown to have a multitude of biological functions (Dickinson and Fleetwood-Walker, 1999; Awawdeh et al., 2002) . VIP was recently reported to have direct antimicrobial activities against both Gram-positive and Gram-negative bacteria (El Karim et al., 2008) . It is, therefore, plausible that the nervous system may deploy some antibacterial function in the form of released neuropeptides, such as VIP, whose delivery to innervated peripheral sites is considered to protect the nervous system from infection by microorganisms.
Orexins are novel hypothalamic neuropeptides that have been implicated in the regulation of feeding, arousal, and energy homeostasis (Kirchgessner, 2002; Ehrström et al., 2005) . They are cleaved from a common precursor molecule, preopro-orexin, forming orexin A and orexin B (de Lecea et al., 1998; Sakurai et al., 1998) . Since neurons and endocrine cells in the gut were found to display orexinlike immunoreactivity, it is implicated that orexins modulate the electrical properties and synaptic inputs of secretomotor neurons in the intestinal system and stimulate colonic motility (Kirchgessner and Liu, 1999) . Besides the roles of neuronal activity mediated by orexins, it is also reported that orexin B (ORXB) modulates the function of peritoneal macrophages through activation of calcium-dependent potassium channels and induces enhancement of phagocytosis in mouse peritoneal macrophages (Ichinose et al., 1998; Ichinose and Watanabe, 2004) . Interestingly, the chemical properties of ORXB, i.e., amino acid composition (28 amino acids), net charge, and isoelectric point, are very similar to those of VIP (Table 1) . Since antimicrobial action of a peptide can be predicted by its chemical properties, especially amphipathic nature and cationic charge (Brogden et al., Journal of Neuroimmunology 233 (2011) 37-45 
